Powered by MOMENTUM MEDIA
lawyers weekly logo
Advertisement
Markets
10 September 2025 by Adrian Suljanovic

Are big banks entering a new cost-control cycle?

Australia’s biggest banks have axed thousands of jobs despite reporting record profits over the year, fuelling concerns over cost-cutting, offshoring ...
icon

How $2.68tn is spread across products and investments

Australia’s $2.68 trillion superannuation system is being shaped not only by the dominance of MySuper and Choice ...

icon

Private credit growth triggers caution at Yarra Capital

As private credit emerges as a fast-growing asset class, Yarra Capital Management remains cautious about the risks that ...

icon

CBA flags end of global rate-cutting cycle

The major bank has indicated that central banks are nearing the end of their rate-cutting cycles, while Trump’s pressure ...

icon

ETF market nears $300bn as international equities lead inflows

The Australian ETF industry is on the cusp of hitting $300 billion in assets under management, with VanEck forecasting ...

icon

Lonsec joins Count in raising doubts over Metrics funds

Lonsec has cut ratings on three Metrics Credit Partners funds, intensifying scrutiny on the private credit manager’s ...

VIEW ALL

Mirrabooka boosts investments

  •  
By Alice Uribe
  •  
2 minute read

Small to mid-cap investment company Mirrabooka has heralded a market recovery as it starts to spend a portion of its cash holding.

Listed investment company Mirrabooka has started to selectively invest money back into the market as it becomes more confident about the economic outlook.

Mirrabooka said the company held a high level of cash throughout 2008/09, but as it became more confident it had increased its investments.

At year end, cash represented 13.1 per cent of the total portfolio.

"Going forward, remaining cash will allow Mirrabooka to participate in attractively priced new issues, which have been recently a feature of the market, or in further investments in stocks that we feel match our investment criteria," Mirrabooka said in a statement.

 
 

The company's top investment at 30 June was Nufarm at $8.3 million. It also ploughed $7.6 million into Oil Search and $7 million into Healthscope.

"Mirrabooka believes that current prices adequately reflect the economic recovery," it said.

The company, which invests in small to medium-sized businesses, said its success for the year ending 30 June reflected the approach it had taken to managing its portfolio.

"The combined small to mid-cap sector fell 27.8 per cent over the year whereas Mirrabooka's portfolio decline was a smaller 19.4 per cent," it said.